Infectious Disease Doctors in Frederick, MD Accepting Medicare

4 Infectious Disease doctors found. Showing 1 - 4

Dr. Arthur Michael Friedlander, M.D. Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1425 Porter St, Frederick, MD 21702 Phone: 301-619-8185    Fax: 301-619-4299

Anusha Belani, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 198 Thomas Johnson Dr, Ste 104, Frederick, MD 21702 Phone: 301-694-0580    Fax: 301-694-0434

Robert G Rivard, MD Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1425 Porter St, Usmariid - Med Division, Frederick, MD 21702 Phone: 301-619-4646    Fax: 210-916-2121

Dr. Bret K Purcell, Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1425 Porter St, Frederick, MD 21702 Phone: 301-619-7175

News Archive

Higher insurance premiums forecast for 2015

With less than two weeks to go in open enrollment, analysts size up the likelihood of reaching signup targets for young people and worry about the impact of that and other factors on 2015 premiums for exchange plans. The role of insurance brokers is also examined.

Johns Hopkins leads first 16-patient, multicenter "domino donor" kidney transplant

Surgical teams at The Johns Hopkins Hospital, Barnes-Jewish Hospital in St. Louis, INTEGRIS Baptist Medical Center in Oklahoma City and Henry Ford Hospital in Detroit successfully completed the first eight-way, multihospital, domino kidney transplant. The transplant involved eight donors - 3 men and 5 women along with eight organ recipients - 3 men and 5 women. "All Johns Hopkins patients are in good condition and are recovering as anticipated," according to Robert A. Montgomery, M.D., Ph.D., director of the Johns Hopkins Comprehensive Transplant Center.

Spherix completes $20M equity financing round

Spherix Incorporated, an intellectual property development company committed to the fostering and monetization of intellectual property, today announced that it has completed a $20 million equity financing consisting of 10 million shares of Series J Convertible Preferred Stock (convertible into common stock) at $2 per share to raise gross proceeds of $20 million, before payment of placement agent fees and other expenses of the offering payable by us.

Earlier treatment with steroids reduces adverse outcomes in patients with septic shock

Some critically ill patients with septic shock need medications called vasopressors to correct dangerously low blood pressure.

Read more Medical News

› Verified 2 days ago